Molecular Basis of Simalikalactone D Sensitivity in Triple-Negative Breast Cancer Cells
Authors:
- Annelis O. Sánchez-ÁlvarezASAnnelis O. Sánchez-Álvarez
- Joshua Nieves-ReyesJNJoshua Nieves-Reyes
- Gabriel Borges-VélezGBGabriel Borges-Vélez
- Josué Pérez-SantiagoJPJosué Pérez-Santiago
- Misael Rivera-GarcíaMRMisael Rivera-García
- Stella Alicea-AyalaSAStella Alicea-Ayala
- Claudia Ospina-MillanClaudia Ospina-Millan
- Fatima ValiyevaFVFatima Valiyeva
- Pablo E. Vivas-MejiaPablo E. Vivas-Mejia
Open Access
- 6 November 2025
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 15 (11) , 1561
Abstract
Background/Objective: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer (BC) lacking targeted therapies and characterized by high tumor heterogeneity. In this study, we evaluated the anticancer activity and mechanistic profile of Simalikalactone D (SKD), a quassinoid compound derived from the endemic Puerto Rican tree Simarouba tulae, in three TNBC cell lines, MDA-MB-468, MDA-MB-231, and SUM-149. Methods: MDA-MB-468, MDA-MB-231 and SUM-149 TNBC cells were evaluated for cell viability, proliferation and migration following SKD treatment. Phospho-antibody array, proteomics, and Western blot analyses were used to explore the SKD mechanism of action in MDA-MB-468 and MDA-MB-231 cell lines. Molecular docking was performed to assess SKD’s interaction with potential intracellular targets. Results: SKD exerted a concentration-dependent effect on the three cell lines. However, MDA-MB-468 cells exhibited an IC50 of 67 nM, while the IC50 values for MDA-MB-231 and SUM-149 were 422 nM and 598 nM, respectively. In MDA-MB-468 cells, 100 nM of SKD induced apoptosis, evidenced by the activated caspase-3 activity, PARP-1 cleavage and decrease in Bcl-2 and survivin protein levels. Sublethal SKD (25 nM) impaired migration in MDA-MB-231 cells and reduced proliferation and motility in SUM149 cells. A 6 h SKD treatment markedly reduced phosphorylation of apoptosis-related proteins (p53, BAD, DAXX, AKT1, JUN) and Jak/STAT pathway components, indicating early disruption of intracellular signaling prior to phenotypic changes. Proteomic profiling showed distinct pathway alterations in both MDA-MB-468 and MDA-MB-231 cells, with reduced Integrin β1 (ITGB1) levels emerging as a shared effector. This suggests that SKD broadly disrupts cell adhesion and migration independently of apoptosis-driven cell death. Western blot validation confirmed reduced ITGB1 protein levels across all three TNBC cell lines examined. In silico docking confirmed favorable binding affinities of SKD to both EGFR (ΔG = −6.718 kcal/mol) and STAT4 (ΔG = −8.481 kcal/mol). Conclusions: Overall, our findings suggest that SKD is a potent anticancer agent in a subgroup of TNBC cells.Keywords
Funding Information
- pilot project program of the NIH PR-INBRE (P20GM103475)
- US Department of Education: Title V Grant Award (P031S200104)
- National Institute on Minority Health and Health Disparities (U54-MD007600)
- “Proteomics Centralized Research Instrumentation Core” of the PR-INBRE program
- Comprehensive Cancer Center for the state-of-the-art research facilities
This publication has 90 references indexed in Scilit:
- LARP4A and LARP4B in cancer: The new kids on the blockThe International Journal of Biochemistry & Cell Biology, 2023
- Zika virus infection of the placenta alters extracellular matrix proteomeJournal of Molecular Histology, 2021
- UCSF ChimeraX: Structure visualization for researchers, educators, and developersProtein Science, 2020
- High triple‐negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancerCancer, 2020
- Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor PrognosisArchives of Medical Research, 2019
- Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilitiesCancer Medicine, 2016
- Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancerBreast Cancer Research and Treatment, 2015
- STAT‐mediated EGFR signaling in cancerJournal of Cellular Biochemistry, 2007
- MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGFBiochemical and Biophysical Research Communications, 1985
- Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterizationIn Vitro Cellular & Developmental Biology - Plant, 1978